Home > Blog Directory > Blog: InPharm
FDA approves Pfizer's lung cancer drug Xalkori | InPharm
Xalkori (crizotinib) is now approved in the US to treat advanced non-small cell lung cancer...
Read more
Date: 2011-08-30 10:32:34
Related topics
: clinical trials non small cell lung cancer /
non small cell lung cancer treatment /
new treatments for lung cancer
Key product launches of 2011 | InPharm
Yervoy (ipilimumab) has been approved as a first and second line treatment for advanced, inoperable...
Read more
Date: 2011-12-19 11:10:19
Related topics
: non small cell lung cancer stage /
treatments /
treatments for lung cancer
Trial disappointment for AZ lung cancer drug | InPharm
The drug failed to meet its primary endpoint of increasing overall survival in the 87 patients with...
Read more
Date: 2011-10-03 09:45:22
Related topics
: locally advanced non small cell lung cancer /
survival rate for lung cancer patients /
lung cancer with metastatic disease
Boehringer will help develop Aveo's lung cancer candidate | InPharm
The agreement is for Boehringer to undertake the large-scale process development and clinical...
Read more
Date: 2011-12-02 10:06:28
Related topics
: clinical trials non small cell lung cancer /
non large cell lung cancer /
lung cancer clinic
4 Resources